Disseminated Mycobacterium bovis infection post‐kidney transplant following remote intravesical BCG therapy for bladder cancer

Intravesical Bacillus Camlette‐Guérin (BCG) is the treatment of choice for non‐muscle invasive bladder cancer, and has been used successfully for over 40 years. A rare and potentially fatal complication of intravesical BCG therapy is BCG‐induced sepsis. We report a rare case in which a patient with...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplant infectious disease 2018-10, Vol.20 (5), p.e12931-n/a
Hauptverfasser:	Ziegler, Jennifer, Ho, Julie, Gibson, Ian W., Nayak, Jasmir G., Stein, Markus, Walkty, Andrew, Orr, Pamela
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical Antitubercular Agents - therapeutic use Bacillus Calmette-Guerin vaccine Bacillus Camlette‐Guérin BCG BCG Vaccine - adverse effects BCG‐induced sepsis BCG‐related infections Biopsy Bladder Bladder cancer Cancer Fatal Outcome Fatalities granulomatous nephritis Humans Immunosuppression Immunosuppression - adverse effects Induction therapy Infections intravesical BCG Kidney Failure, Chronic - surgery Kidney Glomerulus - microbiology Kidney Glomerulus - pathology kidney transplant Kidney transplantation Kidney Transplantation - adverse effects Kidney transplants Kidneys Male Middle Aged Muscles Mycobacterium bovis - isolation & purification Mycobacterium bovis - pathogenicity Mycobacterium Infections, Nontuberculous - drug therapy Mycobacterium Infections, Nontuberculous - immunology Mycobacterium Infections, Nontuberculous - microbiology Nephritis Patients Renal failure Sepsis Therapy Thymoglobulin Transplants Transplants & implants Urinary Bladder Neoplasms - therapy Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!